Suzanne M Gilboa1, Owen J Devine2, James E Kucik2, Matthew E Oster2, Tiffany Riehle-Colarusso2, Wendy N Nembhard2, Ping Xu2, Adolfo Correa2, Kathy Jenkins2, Ariane J Marelli1. 1. From Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities (S.M.G., O.J.D., J.E.K., M.E.O., T.R.-C.), and Office of the Associate Director of Policy (J.E.K.), Centers for Disease Control and Prevention, Atlanta, GA; Carter Consulting, Atlanta, GA (O.J.D.); Children's Healthcare of Atlanta, Emory University School of Medicine, GA (M.E.O.); University of South Florida, Tampa (W.N.N., P.X.); University of Arkansas for Medical Sciences and Arkansas Children's Hospital Research Institute, Little Rock (W.N.N.); University of Mississippi Medical Center, Jackson (A.C.); Children's Hospital Boston, MA (K.J.); and McGill Adult Unit for Congenital Heart Disease, Montreal, QC, Québec (A.J.M.). sgilboa@cdc.gov ariane.marelli@mcgill.ca. 2. From Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities (S.M.G., O.J.D., J.E.K., M.E.O., T.R.-C.), and Office of the Associate Director of Policy (J.E.K.), Centers for Disease Control and Prevention, Atlanta, GA; Carter Consulting, Atlanta, GA (O.J.D.); Children's Healthcare of Atlanta, Emory University School of Medicine, GA (M.E.O.); University of South Florida, Tampa (W.N.N., P.X.); University of Arkansas for Medical Sciences and Arkansas Children's Hospital Research Institute, Little Rock (W.N.N.); University of Mississippi Medical Center, Jackson (A.C.); Children's Hospital Boston, MA (K.J.); and McGill Adult Unit for Congenital Heart Disease, Montreal, QC, Québec (A.J.M.).
Abstract
BACKGROUND: Because of advancements in care, there has been a decline in mortality from congenital heart defects (CHDs) over the past several decades. However, there are no current empirical data documenting the number of people living with CHDs in the United States. Our aim was to estimate the CHD prevalence across all age groups in the United States in the year 2010. METHODS: The age-, sex-, and severity-specific observed prevalence of CHDs in Québec, Canada, in the year 2010 was assumed to equal the CHD prevalence in the non-Hispanic white population in the United States in 2010. A race-ethnicity adjustment factor, reflecting differential survival between racial-ethnic groups through 5 years of age for individuals with a CHD and that in the general US population, was applied to the estimated non-Hispanic white rates to derive CHD prevalence estimates among US non-Hispanic blacks and Hispanics. Confidence intervals for the estimated CHD prevalence rates and case counts were derived from a combination of Taylor series approximations and Monte Carlo simulation. RESULTS: We estimated that ≈2.4 million people (1.4 million adults, 1 million children) were living with CHDs in the United States in 2010. Nearly 300 000 of these individuals had severe CHDs. CONCLUSIONS: Our estimates highlight the need for 2 important efforts: planning for health services delivery to meet the needs of the growing population of adults with CHD and the development of surveillance data across the life span to provide empirical estimates of the prevalence of CHD across all age groups in the United States.
BACKGROUND: Because of advancements in care, there has been a decline in mortality from congenital heart defects (CHDs) over the past several decades. However, there are no current empirical data documenting the number of people living with CHDs in the United States. Our aim was to estimate the CHD prevalence across all age groups in the United States in the year 2010. METHODS: The age-, sex-, and severity-specific observed prevalence of CHDs in Québec, Canada, in the year 2010 was assumed to equal the CHD prevalence in the non-Hispanic white population in the United States in 2010. A race-ethnicity adjustment factor, reflecting differential survival between racial-ethnic groups through 5 years of age for individuals with a CHD and that in the general US population, was applied to the estimated non-Hispanic white rates to derive CHD prevalence estimates among US non-Hispanic blacks and Hispanics. Confidence intervals for the estimated CHD prevalence rates and case counts were derived from a combination of Taylor series approximations and Monte Carlo simulation. RESULTS: We estimated that ≈2.4 million people (1.4 million adults, 1 million children) were living with CHDs in the United States in 2010. Nearly 300 000 of these individuals had severe CHDs. CONCLUSIONS: Our estimates highlight the need for 2 important efforts: planning for health services delivery to meet the needs of the growing population of adults with CHD and the development of surveillance data across the life span to provide empirical estimates of the prevalence of CHD across all age groups in the United States.
Authors: Raluca Ionescu-Ittu; Andrew S Mackie; Michal Abrahamowicz; Louise Pilote; Christo Tchervenkov; Giuseppe Martucci; Ariane J Marelli Journal: Ann Thorac Surg Date: 2010-11 Impact factor: 4.330
Authors: Matthew E Oster; Kyung A Lee; Margaret A Honein; Tiffany Riehle-Colarusso; Mikyong Shin; Adolfo Correa Journal: Pediatrics Date: 2013-04-22 Impact factor: 7.124
Authors: A Carla Zomer; Raluca Ionescu-Ittu; Ilonca Vaartjes; Louise Pilote; Andrew S Mackie; Judith Therrien; Maurice M Langemeijer; Diederick E Grobbee; Barbara J M Mulder; Ariane J Marelli Journal: J Am Coll Cardiol Date: 2013-05-01 Impact factor: 24.094
Authors: Linda Wang; Neeraj Javadekar; Ananya Rajagopalan; Nichole M Rogovoy; Kazi T Haq; Craig S Broberg; Larisa G Tereshchenko Journal: Heart Rhythm Date: 2020-05 Impact factor: 6.343
Authors: Shao Lin; Ziqiang Lin; Yanqiu Ou; Aida Soim; Srishti Shrestha; Yi Lu; Scott Sheridan; Thomas J Luben; Edward Fitzgerald; Erin Bell; Gary M Shaw; Jennita Reefhuis; Peter H Langlois; Paul Romitti; Marcia L Feldkamp; Sadia Malik; Cristian Pantea; Seema Nayak; Syni-An Hwang; Marilyn Browne Journal: Environ Int Date: 2018-06-08 Impact factor: 9.621
Authors: Susan M Fernandes; Amy Verstappen; Mathieu Clair; Mary Rummell; Deena Barber; Kathleen Ackerman; Kirsten Dummer; Joseph C Mares; Mary M Cannobio; Leigh C Reardon; Jin Long; Stephen Crumb; Ami Bhatt; Masato Takahashi; Paul Khairy; Roberta Williams; Michael J Landzberg; Tabitha Moe; Disty Pearson Journal: Pediatr Cardiol Date: 2019-07-31 Impact factor: 1.655
Authors: Sophie C Hofferberth; Mossab Y Saeed; Lara Tomholt; Matheus C Fernandes; Christopher J Payne; Karl Price; Gerald R Marx; Jesse J Esch; David W Brown; Jonathan Brown; Peter E Hammer; Richard W Bianco; James C Weaver; Elazer R Edelman; Pedro J Del Nido Journal: Sci Transl Med Date: 2020-02-19 Impact factor: 17.956
Authors: Alpha Oumar Diallo; Asha Krishnaswamy; Stuart K Shapira; Matthew E Oster; Mary G George; Jenna C Adams; Elizabeth R Walker; Paul Weiss; Mohammed K Ali; Wendy Book Journal: J Am Med Inform Assoc Date: 2018-12-01 Impact factor: 4.497
Authors: Saurabh Rajpal; Laith Alshawabkeh; Nureddin Almaddah; Caroline M Joyce; Keri Shafer; Michelle Gurvitz; Sushrut S Waikar; Finnian R Mc Causland; Michael J Landzberg; Alexander R Opotowsky Journal: JAMA Cardiol Date: 2018-04-01 Impact factor: 14.676